Filing identity and business context
The supplied filing is GX Acquisition Corp.’s unaudited Form 10-Q for the quarter ended March 31, 2020—not a Celularity Inc. filing. GX Acquisition Corp. was a blank-check company seeking a business combination; it had not begun operations and reported no operating revenue. Its stated deadline to complete a business combination was May 23, 2021.
Financial results and liquidity
- Results: Net income was $1.025 million, versus a $121 net loss in Q1 2019. Q1 2020 included $1.109 million of trust-account interest and $430,000 of unrealized gains, offset by $242,000 of operating and formation costs and $273,000 of income tax provision. After allocating trust earnings to redeemable shares, adjusted net loss attributable to other common shares was $128,000; reported basic and diluted loss per share was $0.01.
- Cash flow: Operating activities used $550,000; $138,000 was withdrawn from the trust to pay taxes, and cash declined $412,000 to $505,000.
- Assets and liquidity: At March 31, cash outside the trust was $505,000, while trust-account marketable securities were $292.0 million. Current liabilities were $129,000. The balance sheet included $10.8 million of deferred underwriting fees payable only if a business combination is completed.
- Debt and margins: The company reported no long-term debt and no operating revenue; revenue-based margins are not applicable.
Changes versus prior comparable period
Compared with Q1 2019, the company moved from a nominal loss to net income, primarily because it held substantial trust investments after its May 2019 IPO. Operating and formation costs rose to $242,000 from $121. Cash used in operations increased to $550,000 from $676.
Outlook, risks and unusual items
- Management expected continued costs to identify and pursue a business combination and said it did not expect to need additional funds for planned expenditures, while cautioning that actual costs or significant shareholder redemptions could create a funding shortfall or require additional financing.
- Public shareholders could redeem shares upon a business combination. If no combination closed by May 23, 2021, the company was required to wind up and redeem public shares; warrants could expire worthless.
- The sponsor’s trust-protection indemnity was limited, and the filing said the sponsor’s ability to satisfy it could not be assured. A business combination could also involve material dilution or debt-related risks.
- Management reported no material change to the risk factors in its 2019 Form 10-K, no legal proceedings, and no subsequent event requiring disclosure. Disclosure controls were assessed as effective, with no material change in internal control reported.
Important facts to verify
- Confirm the intended issuer: this document identifies GX Acquisition Corp., not Celularity Inc.
- Review the trust balance, redemption terms, and May 23, 2021 business-combination deadline.
- Assess the limited cash available outside the trust against ongoing transaction expenses and potential financing needs.
- Check the source filing for the precise presentation of per-share results: the statements show positive net income, while the redeemable-share allocation produces an adjusted loss per share.